Abstract
2,3-Butanedione monoxime (BDM) is the well-characterized, low-affinity, non-competitive inhibitor of skeletal muscle myosin-II. It has been widely used at millimolar concentrations in cell biological experiments with the assumption that it is an ATPase inhibitor of the myosin superfamily. To determine the usefulness of BDM as a general myosin inhibitor, the ATPase activities of the motor domains of skeletal muscle myosin-II, Acanthamoeba myosin-IC, human myole, chicken myosin-V, and porcine myosin-VI were measured in the presence of 0–40 mM BDM. BDM inhibits skeletal muscle myosin-II, but it does not inhibit the ATPase activity of the other myosins. Therefore, BDM is not a general inhibitor of the myosin ATPase. BDM has a broad effect on many non-myosin proteins (many uncharacterized), and thus should not be used in whole-cell experiments as a myosin inhibitor.
Similar content being viewed by others
References
Cheung A, Dantzig JA, Hollingworth S, Baylor SM, Goldman YE, Mitchison TJ and Straight AF (2002) A small-molecule inhibitor of skeletal muscle myosin-II. Nature Cell Biol 4: 83-88.
Cramer LP and Mitchison TJ (1995) Myosin is involved in postmitotic cell spreading. J Cell Biol 131: 179-189.
De La Cruz EM, Ostap EM and Sweeney HL (2001) Kinetic mechanism and regulation of myosin VI. J Biol Chem 276: 32,373-32,381.
De La Cruz EM, Sweeney HL and Ostap EM (2000) ADP inhibition of myosin V ATPase activity. Biophys J 79: 1524-1529.
El Mezgueldi M, Tang N, Rosenfeld S and Ostap EM (2002) The kinetic mechanism of myole (human myosin-IC). J Biol Chem 277: (in press).
Ferreira G, Artigas P, Pizarro G and Brum G (1997) Butanedione monoxime promotes voltage-dependent inactivation of L-type calcium channels in heart. Effects on gating currents. J Mol Cell Cardiol 29: 777-787.
Furch M, Geeves MA and Manstein DJ (1998) Modulation of actin a.nity and actomyosin adenosine triphosphatase by charge changes in the myosin motor domain. Biochemistry 37: 6317-6326.
Herrmann C, Wray J, Travers F and Barman T (1992) Effect of 2,3-butanedione monoxime on myosin and myofibrillar ATPases. An example of an uncompetitive inhibitor. Biochemistry 31: 12,227-12,232.
Higuchi H and Takemori S (1989) Butanedione monoxime suppresses contraction and ATPase activity of rabbit skeletal muscle. J Biochem 105: 638-643.
Johnson KA and Taylor EW (1978) Intermediate states of subfragment 1 and actosubfragment 1 ATPase: reevaluation of the mechanism. Biochemistry 17: 3432-3442.
Lopatin AN and Nichols CG (1993) Block of delayed rectifier (DRK1) K+ channels by internal 2,3-butanedione monoxime in Xenopus oocytes. Receptors Channels 1: 279-286.
McCurdy DW (1999) Is 2,3-butanedione monoxime an effective inhibitor of myosin-based activities in plant cells? Protoplasma 209: 120-125.
McKillip DFA, Fortune NS, Ranatunga KW and Geeves MA (1994) The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibers. J Muscle Res Cell Motil 15: 309-318.
Schlichter LC, Pahapill PA and Chung I (1992) Dual action of 2,3-butanedione monoxime (BDM) on K+ current in human T lymphocytes. J Pharmacol Exp Ther 261: 438-446.
Sellers JR (1999) Myosins. Oxford University Press, Oxford, UK, 237 pp.
Sellin LC and McArdle JJ (1994) Multiple effects of 2,3-butanedioine monoxime. Pharmacol Toxicol 74: 305-313.
Siegman MJ, Mooers SU, Warren TB, Warshaw DM, Ikebe M and Butler TM (1994) Comparison of the effects of 2,3-butanedione monoxime on force production, myosin light chain phosphorylation and chemical energy usage in intact and permeabilized smooth and skeletal muscles. J Mus Res Cell Motil 15: 457-472.
Spudich JA and Watt S (1971) The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. J Biol Chem 246: 4866-4871.
Stapleton MT, Fuchsbauer CM and Allshire AP (1998) BDM drives protein dephosphorylation and inhibits adenine nucleotide exchange in cardiomyocytes. Am J Physiol 275: H1260-H1266.
Verrecchia F and Herve´ JC (1997) Reversible blockade of gap junctional communication by 2,3-butanedione monoxime in rat cardiomyocytes. Am J Physiol 272: C875-C885.
Wagner PD and Yount RG (1975) Stoichiometry of labeling of myosin's proteolytic fragments by a purine disulfide analog of adenosine triphosphate. Biochemistry 14: 1900-1907.
Wilson IB and Ginsburg S (1955) A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochem Biophys Acta 18: 168-175.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ostap, E.M. 2,3-Butanedione monoxime (BDM) as a myosin inhibitor. J Muscle Res Cell Motil 23, 305–308 (2002). https://doi.org/10.1023/A:1022047102064
Issue Date:
DOI: https://doi.org/10.1023/A:1022047102064